Site icon OncologyTube

Importance of performance status prior to starting regorafenib at Annual Meeting GI 2016

Alan P. Venook, MD of University of California San Francisco discusses the importance of performance status prior to starting regorafenib at ASCO GI 2016

Exit mobile version